Características clínicas y pronósticas del carcinoma familiar de tiroides no medular

American Cancer Society, 2020 [consultada 13 Dic 2020]. Disponible en: https://www.cancer.org/cancer/thyroid-cancer/detection-diagnosis-staging/survival-rates.html. Capezzone, 2008, Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity, Endocr Relat Cancer., 15, 1075, 10.1677/ERC-08-0080 Cancer Statistics Center, 2020 [consultada 13 Dic 2020]. Disponible en: https://cancerstatisticscenter.cancer.org/#!/. Davies, 2006, Increasing incidence of thyroid cancer in the United States, 1973-2002, JAMA., 295, 2164, 10.1001/jama.295.18.2164 Haugen, 2016, 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer, Thyroid., 26, 1, 10.1089/thy.2015.0020 Capezzone, 2020, Familial non-medullary thyroid cancer: A critical review, J Endocrinol Invest., 44, 943, 10.1007/s40618-020-01435-x Zhang, 2018, Familial nonmedullary thyroid carcinoma: A retrospective analysis of 117 families, Chin Med J (Engl)., 131, 395, 10.4103/0366-6999.225054 Charkes, 2006, On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds, Thyroid., 16, 943, 10.1089/thy.2006.16.181 Frich, 2001, Familial occurrence of nonmedullary thyroid cancer: A population-based study of 5673 first-degree relatives of thyroid cancer patients, Cancer Epidemiol Biomarkers Prev., 10, 113 Fallah, 2013, Risk of thyroid cancer in fi rst-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: A joint study from five Nordic countries, J Med Genet., 50, 373, 10.1136/jmedgenet-2012-101412 Ito, 2004, Biological behavior and prognosis of familial papillary thyroid carcinoma, Surgery [Internet]., 145, 100, 10.1016/j.surg.2008.08.004 Orois, 2020, Familial non medullary thyroid carcinoma: Beyond the syndromic forms, Endocrinol Diabetes Nutr [Engl Ed]., 68, 260 Vriens, 2009, Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer, Thyroid., 19, 1343, 10.1089/thy.2009.1607 Cantara, 2012, Telomere abnormalities and chromosome fragility in patients affected by familial papillary thyroid cancer, Adv Genet Res., 97, 1327 Hińcza, 2019, Current knowledge of germline genetic risk factors for the development of non-medullary thyroid cancer, Genes (Basel)., 10, 482, 10.3390/genes10070482 El Lakis, 2019, Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment, Surgery., 165, 50, 10.1016/j.surg.2018.05.075 Cao, 2016, Clinicopathological features and prognosis of familial papillary thyroid carcinoma —A large-scale, matched, case-control study, Clin Endocrinol (Oxf)., 84, 598, 10.1111/cen.12859 Robenshtok, 2011, Clinical characteristics and outcome of familial nonmedullary thyroid cancer: A retrospective controlled study, Thyroid., 21, 43, 10.1089/thy.2009.0406 Edge, 2010, The american joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM, Ann Surg Oncol., 17, 1471, 10.1245/s10434-010-0985-4 Moses, 2011, Genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer, Thyroid., 21, 367, 10.1089/thy.2010.0256 Park, 2012, The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases, Thyroid., 22, 356, 10.1089/thy.2011.0163 Wang, 2015, Familial nonmedullary thyroid carcinoma is a more aggressive disease: A systematic review and meta-analysis, Eur J Endocrinol., 172, R253, 10.1530/EJE-14-0960 Domínguez, 2018, Papillary thyroid microcarcinoma: Characteristics at presentation, and evaluation of clinical and histological features associated with a worse prognosis in a Latin American cohort, Arch Endocrinol Metab., 62, 6, 10.20945/2359-3997000000013 Zhang, 2016, Clinical analysis of familial nonmedullary thyroid carcinoma, World J Surg., 40, 570, 10.1007/s00268-015-3342-8 Alsanea, 2000, Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series, Surgery, 128, 1043, 10.1067/msy.2000.110848 McDonald, 2011, Familial papillary thyroid carcinoma: A retrospective analysis, J Oncol., 2011, 948786, 10.1155/2011/948786 Zhou, 2017, Second generation of familial nonmedullary thyroid carcinoma: A meta-analysis on the clinicopathologic features and prognosis, Eur J Surg Oncol [Internet]., 43, 2248, 10.1016/j.ejso.2017.09.005 Hemminki, 2005, Familial risks for nonmedullary thyroid cancer, J Clin Endocrinol Metab., 90, 5747, 10.1210/jc.2005-0935 Emminki, 2003, Familial risk of cancer by site and histopathology, Int J Cancer., 103, 105, 10.1002/ijc.10764 Derwahl, 2014, Estrogen and its role in thyroid cancer, Endocr Relat Cancer., 21, T273, 10.1530/ERC-14-0053 Zane, 2017, Estrogen and thyroid cancer is a stem affair: A preliminary study, Biomed Pharmacother., 85, 399, 10.1016/j.biopha.2016.11.043 Tavarelli, 2015, Familial non-medullary thyroid cancer represents an independent risk factor for increased cancer aggressiveness: A retrospective analysis of 74 families, Front Endocrinol (Lausanne)., 6, 1, 10.3389/fendo.2015.00117